Stay updated on APL-2 in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.

Latest updates to the APL-2 in Neovascular AMD Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changed from Revision: v3.6.4 to Revision: v3.6.5, indicating a minor site update that does not modify study details.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's Revision label changed from v3.6.3 to v3.6.4, signaling a newer revision of the page without modifying the underlying study information.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe revision label was updated from v3.6.2 to v3.6.3, indicating a software release for the interface. This update does not modify the study content or how information is presented on the page.SummaryDifference0.1%

- Check47 days agoChange DetectedA new page revision tag v3.6.2 has been added, replacing the previous v3.6.0 in the page's revision history. This signals a small update to the page metadata without altering study information presented.SummaryDifference0.1%

- Check61 days agoChange DetectedRecruitment has ended for this study page, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a formatting tweak to the Intervention/Treatment heading and a Revision: v3.6.0 note.SummaryDifference0.6%

- Check68 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5 to reflect a minor site release; no study content appears to be changed.SummaryDifference0.1%

Stay in the know with updates to APL-2 in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.